ALEMBIC PHARMA LTD Share Price, Financial Results, Charts & Analysis

ALEMBIC PHARMA LTD (APLLTD)

NSE: ₹737.55

BSE: ₹735.70

Corporate Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Please find enclosed herewith Intimation of One of One Meet.

2026-06-19 17:10:13

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Please find enclosed herewith Intimation of One on One Meet.

2026-06-19 17:08:02

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Please find enclosed herewith Intimation of One on One Meet.

2026-06-19 17:04:18

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Limited received USFDA Tentative Approval for Binimetinib Tablets, 45 mg.

2026-06-19 12:57:13

Announcement under Regulation 30 (LODR)-Change in Directorate

Appointment of Mr. Sujit Bhayani as Non-Executive Independent Director of the Company w.e.f. 18th June, 2026.

2026-06-18 21:34:08

Particulars	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue from Operations	1,332.27	1,478.84	1,588.39	1,474.55	1,475.56	1,580.35	1,406.09	1,570.64	1,494.17	1,796.24	1,642.24	1,718.74
YOY Revenue Growth %	14.82%	9.19%	21.23%	12.81%	10.75%	6.86%	-11.48%	6.52%	1.26%	13.66%	16.8%	9.43%
Other Income	11.84	8.95	3.30	7.22	3.15	16.06	15.46	13.21	7.79	11.49	10.73	25.88
Total Income	1,344.12	1,487.80	1,591.69	1,481.78	1,478.70	1,596.41	1,421.55	1,583.85	1,501.96	1,807.73	1,652.97	1,744.62
Total Expenses +	1,246.59	1,353.95	1,334.99	1,265.61	1,265.50	1,409.26	1,317.74	1,492.29	1,376.44	1,591.38	1,471.96	1,546.40
Cost of Materials Consumed	334.19	413.87	317.58	337.38	405.93	393.14	446.91	426.20	431.27	463.14	448.73	404.24
Employee Benefit Expense	327.47	326.41	327.11	354.92	356.51	367.61	369.18	373.27	396.40	408.12	401.36	407.02
Other Expenses	422.13	475.50	431.53	410.11	439.01	481.20	478.78	476.92	466.76	500.90	464.59	522.72
Operating Profit	85.68	124.89	253.40	208.94	210.06	171.09	88.34	78.35	117.73	204.86	170.28	172.34
OPM %	6.4%	8.4%	16%	14.2%	14.2%	10.8%	6.3%	5%	7.9%	11.4%	10.4%	10%
Profit Before Tax +	97.53	133.84	256.70	216.16	213.20	200.02	103.81	91.56	125.52	216.35	138.78	173.46
Tax Expense	0.00	0.00	23.46	14.29	37.01	34.24	18.00	16.22	22.00	36.99	24.31	-69.61
Tax %	0%	0%	9.1%	6.6%	17.4%	17.1%	17.3%	17.7%	17.5%	17.1%	17.5%	-40.1%
Profit After Tax	97.53	133.84	233.24	201.87	176.19	165.78	85.81	75.34	103.52	179.36	114.47	243.07
EPS (Basic)	4.96	6.81	11.87	10.27	8.96	8.43	4.37	3.83	5.27	9.12	5.82	12.37

Particulars

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Revenue from Operations

1,332.27

1,478.84

1,588.39

1,474.55

1,475.56

1,580.35

1,406.09

1,570.64

1,494.17

1,796.24

1,642.24

1,718.74

YOY Revenue Growth %

14.82%

9.19%

21.23%

12.81%

10.75%

6.86%

-11.48%

6.52%

1.26%

13.66%

16.8%

9.43%

Other Income

11.84

8.95

3.30

7.22

3.15

16.06

15.46

13.21

7.79

11.49

10.73

25.88

Total Income

1,344.12

1,487.80

1,591.69

1,481.78

1,478.70

1,596.41

1,421.55

1,583.85

1,501.96

1,807.73

1,652.97

1,744.62

Total Expenses +

1,246.59

1,353.95

1,334.99

1,265.61

1,265.50

1,409.26

1,317.74

1,492.29

1,376.44

1,591.38

1,471.96

1,546.40

Cost of Materials Consumed

334.19

413.87

317.58

337.38

405.93

393.14

446.91

426.20

431.27

463.14

448.73

404.24

Employee Benefit Expense

327.47

326.41

327.11

354.92

356.51

367.61

369.18

373.27

396.40

408.12

401.36

407.02

Other Expenses

422.13

475.50

431.53

410.11

439.01

481.20

478.78

476.92

466.76

500.90

464.59

522.72

Operating Profit

85.68

124.89

253.40

208.94

210.06

171.09

88.34

78.35

117.73

204.86

170.28

172.34

OPM %

6.4%

8.4%

16%

14.2%

10.8%

6.3%

7.9%

11.4%

10.4%

10%

Profit Before Tax +

97.53

133.84

256.70

216.16

213.20

200.02

103.81

91.56

125.52

216.35

138.78

173.46

Tax Expense

0.00

23.46

14.29

37.01

34.24

18.00

16.22

22.00

36.99

24.31

-69.61

Tax %

9.1%

6.6%

17.4%

17.1%

17.3%

17.7%

17.5%

17.1%

17.5%

-40.1%

Profit After Tax

97.53

133.84

233.24

201.87

176.19

165.78

85.81

75.34

103.52

179.36

114.47

243.07

EPS (Basic)

4.96

6.81

11.87

10.27

8.96

8.43

4.37

3.83

5.27

9.12

5.82

12.37

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue from Operations	6,651.38	6,032.63	5,874.06	5,149.00	4,996.61	5,051.44	4,132.55
YOY Revenue Growth %	10.26%	2.7%	14.08%	3.05%	-1.09%	22.24%	-
Other Income	55.90	47.88	31.32	3.55	49.98	9.73	134.75
Total Income	6,707.28	6,080.51	5,905.38	5,152.54	5,046.58	5,061.18	4,267.31
Total Expenses +	5,986.18	5,484.79	5,201.15	4,806.61	4,138.13	3,644.58	2,861.90
Cost of Materials Consumed	1,747.38	1,672.17	1,403.01	1,250.08	1,111.75	1,175.71	978.13
Employee Benefit Expense	1,612.91	1,466.57	1,335.91	1,094.82	1,028.18	948.27	806.37
Other Expenses	1,954.96	1,875.90	1,739.28	1,729.71	1,430.45	1,233.03	1,077.40
Operating Profit	665.20	547.84	672.91	342.39	858.48	1,406.87	1,270.65
OPM %	10%	9.1%	11.5%	6.6%	17.2%	27.9%	30.7%
Profit Before Exceptional	721.10	595.72	704.23	345.93	908.45	1,416.60	1,176.79
Exceptional Items	-66.99	12.87	0.00	0.00	0.00	0.00	-10.00
Profit Before Tax +	654.11	608.59	704.23	345.93	908.45	1,416.60	1,166.79
Tax Expense	13.69	105.47	37.75	-0.80	114.45	241.21	197.39
Tax %	2.1%	17.3%	5.4%	-0.2%	12.6%	17%	16.9%
Profit After Tax	640.42	503.12	666.48	346.73	794.00	1,175.39	969.41
EPS (Basic)	32.58	25.60	33.91	17.64	40.39	60.67	51.42

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Revenue from Operations

6,651.38

6,032.63

5,874.06

5,149.00

4,996.61

5,051.44

4,132.55

YOY Revenue Growth %

10.26%

2.7%

14.08%

3.05%

-1.09%

22.24%

Other Income

55.90

47.88

31.32

3.55

49.98

9.73

134.75

Total Income

6,707.28

6,080.51

5,905.38

5,152.54

5,046.58

5,061.18

4,267.31

Total Expenses +

5,986.18

5,484.79

5,201.15

4,806.61

4,138.13

3,644.58

2,861.90

Cost of Materials Consumed

1,747.38

1,672.17

1,403.01

1,250.08

1,111.75

1,175.71

978.13

Employee Benefit Expense

1,612.91

1,466.57

1,335.91

1,094.82

1,028.18

948.27

806.37

Other Expenses

1,954.96

1,875.90

1,739.28

1,729.71

1,430.45

1,233.03

1,077.40

Operating Profit

665.20

547.84

672.91

342.39

858.48

1,406.87

1,270.65

OPM %

10%

9.1%

11.5%

6.6%

17.2%

27.9%

30.7%

Profit Before Exceptional

721.10

595.72

704.23

345.93

908.45

1,416.60

1,176.79

Exceptional Items

-66.99

12.87

0.00

-10.00

Profit Before Tax +

654.11

608.59

704.23

345.93

908.45

1,416.60

1,166.79

Tax Expense

13.69

105.47

37.75

-0.80

114.45

241.21

197.39

Tax %

2.1%

17.3%

5.4%

-0.2%

12.6%

17%

16.9%

Profit After Tax

640.42

503.12

666.48

346.73

794.00

1,175.39

969.41

EPS (Basic)

32.58

25.60

33.91

17.64

40.39

60.67

51.42

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
ASSETS
Non-Current Assets +	4,120.24	3,790.07	3,409.99	3,350.20	4,922.96	4,402.23	0.00
Property, Plant & Equipment	2,828.42	2,513.47	2,535.66	2,377.45	1,472.13	1,452.83	0.00
Capital Work in Progress	633.70	837.23	524.36	601.28	2,200.22	1,927.63	0.00
Non-Current Investments	271.40	259.56	226.68	229.27	1,209.79	978.25	0.00
Goodwill	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Intangible Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets +	4,001.01	3,766.20	2,988.55	2,780.22	2,612.53	2,373.95	0.00
Inventories	2,048.16	1,976.34	1,353.07	1,275.13	1,367.62	1,316.78	0.00
Trade Receivables	1,603.75	1,480.67	1,340.12	1,201.20	975.13	407.90	0.00
Cash and Cash Equivalents	22.67	14.23	20.13	21.67	11.10	53.44	0.00
Current Investments	0.00	0.00	0.00	0.00	0.00	186.97	0.00
LIABILITIES & EQUITY
Total Equity	5,615.26	5,194.74	4,908.91	4,414.30	5,769.47	5,254.24	0.00
Equity Share Capital	39.31	39.31	39.31	39.31	39.31	39.31	0.00
Other Equity	5,575.95	5,155.43	4,869.60	4,374.98	5,730.16	5,214.93	0.00
Non-Current Liabilities	179.84	161.93	162.42	164.83	199.99	398.48	0.00
Current Liabilities	2,356.15	2,199.60	1,327.21	1,551.29	1,566.04	1,123.46	0.00
Total Liabilities	2,535.99	2,361.53	1,489.63	1,716.12	1,766.02	1,521.94	0.00

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

ASSETS

Non-Current Assets +

4,120.24

3,790.07

3,409.99

3,350.20

4,922.96

4,402.23

0.00

Property, Plant & Equipment

2,828.42

2,513.47

2,535.66

2,377.45

1,472.13

1,452.83

0.00

Capital Work in Progress

633.70

837.23

524.36

601.28

2,200.22

1,927.63

0.00

Non-Current Investments

271.40

259.56

226.68

229.27

1,209.79

978.25

0.00

Goodwill

0.00

Other Intangible Assets

0.00

Current Assets +

4,001.01

3,766.20

2,988.55

2,780.22

2,612.53

2,373.95

0.00

Inventories

2,048.16

1,976.34

1,353.07

1,275.13

1,367.62

1,316.78

0.00

Trade Receivables

1,603.75

1,480.67

1,340.12

1,201.20

975.13

407.90

0.00

Cash and Cash Equivalents

22.67

14.23

20.13

21.67

11.10

53.44

0.00

Current Investments

0.00

186.97

0.00

LIABILITIES & EQUITY

Total Equity

5,615.26

5,194.74

4,908.91

4,414.30

5,769.47

5,254.24

0.00

Equity Share Capital

39.31

0.00

Other Equity

5,575.95

5,155.43

4,869.60

4,374.98

5,730.16

5,214.93

0.00

Non-Current Liabilities

179.84

161.93

162.42

164.83

199.99

398.48

0.00

Current Liabilities

2,356.15

2,199.60

1,327.21

1,551.29

1,566.04

1,123.46

0.00

Total Liabilities

2,535.99

2,361.53

1,489.63

1,716.12

1,766.02

1,521.94

0.00

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activities	809.46	226.57	772.77	730.25	621.15	1,485.30
Cash from Investing Activities	-483.43	-636.08	-329.02	-460.98	-447.36	-925.55
Cash from Financing Activities	-317.59	403.61	-445.29	-261.16	-216.13	-533.61
Net Increase/Decrease in Cash	8.44	-5.90	-1.54	8.11	-42.34	25.21

Particulars

Mar 2026

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Cash from Operating Activities

809.46

226.57

772.77

730.25

621.15

1,485.30

0.00

Cash from Investing Activities

-483.43

-636.08

-329.02

-460.98

-447.36

-925.55

0.00

Cash from Financing Activities

-317.59

403.61

-445.29

-261.16

-216.13

-533.61

0.00

Net Increase/Decrease in Cash

8.44

-5.90

-1.54

8.11

-42.34

25.21

0.00

ALEMBIC PHARMA LTD (APLLTD)

Stock Performance

Corporate Announcements

Quarterly Financials

Yearly Financial Results

Balance Sheet

Cash Flow Statement